Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Aquaculture Vaccines Market

Aquaculture Vaccines Market Share

Report ID: GMI3323
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Aquaculture Vaccines Market Share

The competitive landscape of the market is characterized by a mix of well-established multinational companies and specialized players, all vying for market share in an industry driven by increasing demand for sustainable seafood production and the need for disease prevention in fish farming. Key players in the market include global biotechnology firms such as Merck Animal Health, and Zoetis, which offer a range of vaccines targeting common aquaculture diseases.

Additionally, regional players also contribute to market competition with tailored vaccine solutions suited for specific geographical needs. Collaboration between academia, industry, and government bodies is also a critical factor that impacts innovation and product development, as aquaculture vaccine companies aim to meet the evolving challenges of disease management in aquaculture systems.

Aquaculture Vaccines Market Companies

Few of the prominent players operating in the aquaculture vaccines industry include:

CIBA
HIPRA
Kyoto Biken Laboratories
Kemin Industries
Kyoritsuseiyaku Corporation
Merck Animal Health (Merck & Co.)
Nisseiken
Phibro Animal Health Corporation
Tecnovax
Virbac
Veterquimica
Vaxxinova International
Zoetis

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global aquaculture vaccines industry was valued at USD 407.4 million in 2024 and is estimated to grow at a CAGR of 8% from 2025 to 2034, driven by increasing global demand for seafood and sustainable aquaculture practices.

The inactivated vaccine segment was valued at USD 302.6 million in 2024, holding a significant market share due to its proven safety and efficacy in protecting fish populations against various bacterial and viral diseases.

The European region dominates the aquaculture vaccines industry, with Norway's market valued at USD 85.4 million in 2024, driven by its robust aquaculture industry, particularly in salmon farming.

Key players in the sector include CIBA, HIPRA, Kyoto Biken Laboratories, Kemin Industries, Kyoritsuseiyaku Corporation, Merck Animal Health (a division of Merck & Co.), Nisseiken, Phibro Animal Health Corporation, Tecnovax, Virbac, and Veterquimica.